Clinical trial
A Randomized Comparison of Sirolimus-eluting Stent Implantation With Zotarolimus-eluting Stent Implantation for the Treatment of Chronic Total Coronary Occlusions. The PRISON III Trial.
NCT00428454 is registered in ClinicalTrials.gov with R&D Cardiologie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Comparison of Sirolimus-eluting Stent Implantation With Zotarolimus-eluting Stent Implantation for the Treatment of Chronic Total Coronary Occlusions. The PRISON III Trial.
- Lead sponsor
- R&D Cardiologie
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- June 30, 2015
- Enrollment
- 301 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.